Journal article icon

Journal article : Review

Cardiac resident macrophages: the emerging role in arrhythmogenesis

Abstract:
Arrhythmia is a prevalent complication associated with various cardiovascular diseases. The onset of cardiac disease or injury can impair the normal function of cardiomyocytes, thereby precipitating arrhythmic events. Moreover, non-cardiomyocytes, including immune cells, may also play a contributory role in arrhythmogenesis. For instance, processes such as the infiltration of inflammatory cells that secrete pro-inflammatory mediators, fibroblast-to-myofibroblast transformation, and endothelial-to-mesenchymal transition have all been implicated in this process. Recent investigations have identified a distinct subset of resident macrophages within cardiac tissue that exhibit functional properties differing from those of bone marrow-derived macrophages. Cardiac tissue-resident macrophages (CRMs) are distinguished from bone marrow-derived macrophages by their developmental origin, transcriptomic profile, and functional traits. Beyond their canonical immune functions shared with bone marrow-derived macrophages, CRMs uniquely contribute to cardiac homeostasis by exerting direct electrophysiological modulation via ion channels and gap junctions. This constitutes a distinct mechanism underlying their role in arrhythmogenesis. Advanced methodologies, such as patch-clamp electrophysiology, high-throughput sequencing, and proteomic analyses in mammalian models, have revealed the complex electrophysiological interactions between CRMs and cardiomyocytes. While both CRMs and bone marrow-derived macrophages play roles in arrhythmia initiation and progression, existing reviews have primarily focused on bone marrow-derived macrophages. This review seeks to clarify the electrophysiological properties of CRMs and to delineate the specific mechanisms through which these cells contribute to arrhythmogenesis, thereby providing novel perspectives for the development of anti-arrhythmic therapeutic strategies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fimmu.2026.1753815

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Sub department:
Pharmacology
Role:
Author


More from this funder
Funder identifier:
https://ror.org/04kxx2q73
Grant:
2023JYJ004, 2024LZXNYDJ006
More from this funder
Funder identifier:
https://ror.org/01h0zpd94
Grant:
82270334, 82470323
More from this funder
Funder identifier:
https://ror.org/04323m874
Grant:
2025ZNSFSC0052, 2025HJPJ0005


Publisher:
Frontiers Media
Journal:
Frontiers in Immunology More from this journal
Volume:
17
Pages:
1753815
Article number:
1753815
Publication date:
2026-02-02
Acceptance date:
2026-01-09
DOI:
EISSN:
1664-3224
ISSN:
1664-3224


Language:
English
Keywords:
Subtype:
Review
Source identifiers:
3762709
Deposit date:
2026-02-16
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP